Annette Wu

Antibody-drug conjugates TK study using Gyrolab xP workstation 

Annette Wu in the PDM group at Pfizer, La Jolla, CA, USA, presented ‘Case study: Antibody-drug conjugates TK study on the Gyrolab immunoassay platform at Gyrolab Seminar, USA. This study demonstrates how Gyrolab platform speeds up ADC assay development and throughput.

Using Design of Experiments and Gyrolab xP, the PDM group developed 3 assays for 5 ADCs to GxP quality in 6 days. Gyrolab xP helped them to boost throughput to 1200 samples in 6 days.

View Seminar